GM Advisory Group, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.

Quarter-by-quarter ownership
GM Advisory Group, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$248,000
-8.5%
2,464
+28.7%
0.02%
-10.7%
Q2 2021$271,000
-40.3%
1,914
-47.8%
0.03%
-54.1%
Q4 2020$454,000
+46.0%
3,669
+15.1%
0.06%
+27.1%
Q3 2020$311,000
-34.5%
3,189
+4.8%
0.05%
-45.5%
Q2 2020$475,000
+17.6%
3,043
+8.7%
0.09%
-20.0%
Q1 2020$404,0002,8000.11%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders